Chris Lewis
Stock Analyst at Roth Capital
(3.08)
# 1,145
Out of 4,765 analysts
13
Total ratings
90%
Success rate
57.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $8.09 | -50.56% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $51.44 | -68.90% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $17.16 | -15.50% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $43.04 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $0.97 | +1,961.86% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $8.09
Upside: -50.56%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $51.44
Upside: -68.90%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $17.16
Upside: -15.50%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $43.04
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $0.97
Upside: +1,961.86%